CONTROLLED RELEASE OF MYOTIC AND MYDRIATIC MEDICAMENTS IN THE FRONT OCCULAR CHAMBER

摘要

The invention relates to compositions finding application inophthalmic surgery for maintaining the structural integrity of thefront occular chamber protecting the tissues forming the frontpart from any possible damage and simultaneously ensuring thecontinuous release of a nyotic or mydriatic agent. The inventionrelates to compositions containing highly elastic polymer, and thecontinuous release of the myotic or mydriatic agent is made byionic interaction, and to compositions where the continuousrelease of these agents is made by microcapsules or copolymermycelium25 cliams, 2 figures